EP2395968
Lyfjasamsetning sem inniheldur glúkópýranósýl-dífenýlmetan-afleiður, lyfjaskammtaform þar af, aðferð til framleiðslu á þeim og notkun á þeim fyrir bætta sykurstjórn í sjúklingi
:
EP einkaleyfi í gildi á Íslandi:
11.2.2010:
17.1.2024:
10703652.7
:
25.3.2024:
15.5.2024
:
10.2.2030:
10.2.2026:
28.2.2026
:
PHARMACEUTICAL COMPOSITION COMPRISING GLUCOPYRANOSYL DIPHENYLMETHANE DERIVATIVES, PHARMACEUTICAL DOSAGE FORM THEREOF, PROCESS FOR THEIR PREPARATION AND USES THEREOF FOR IMPROVED GLYCEMIC CONTROL IN A
11.2.2010
17.1.2024
25.3.2024
15.5.2024
10.2.2026
:
Boehringer Ingelheim International GmbH:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
:
EISENREICH, Wolfram:
55216 Ingelheim Am Rhein, DE
:
LADYZHYNSKY, Nadia S.:
Ridgefield, CT 06877, US
:
LI, Danping:
Ridgefield, CT 06877, US
:
SCHULTZ, Leon:
Ridgefield, CT 06877, US
:
WANG, Zeren:
Ridgefield, CT 06877, US
:
MACHA, Sreeraj:
Ridgefield, CT 06877, US
:
BARTA, Albert:
55216 Ingelheim Am Rhein, DE
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
152317 P:
13.2.2009:
US
:
254033 P:
22.10.2009:
US
:
EP2010051737:
11.2.2010
:
A61K 9/00, A61K 9/16, A61K 9/20, A61K 31/431, A61K 31/7004, A61P 3/04, A61P 3/06, A61P 3/10, A61K 9/48, A61P 3/00, A61P 3/08
: 15
: 20.2.2024
: 10.2.2025
: G.H. Sigurgeirsson ehf.
: 16
: 11.2.2025
: 10.2.2026
: G.H. Sigurgeirsson ehf.